PEOPLE

Megan S. Lim, MD, PhD

Professor of Pathology and Laboratory Medicine at the Hospital of the University of Pennsylvania
University of Pennsylvania Perelman School of Medicine
Director, Hematopathology

Contact InformationDepartment of Pathology and Laboratory Medicine
Stellar Chance Office Suite 609C
422 Curie Blvd.

Philadelphia, PA, 19104
Office: 215-898-4719
Fax: 215-898-9969

Email: Megan.Lim@pennmedicine.upenn.edu

Specialty Division

Hematopathology

Itmat Expertise

hematologic cancer
molecular pathogenesis
genomic analysis
mass spectrometry driven proteomics

Education

BS (Cell and Microbiology), University of Calgary, 1983
MS (Biochemistry, Cell Regulation Group, Department of Medical Biochemistry, Faculty of Medicine), University of Calgary, 1985
MD (Medicine), University of Calgary, 1988
PhD (Molecular Oncology), University of Calgary joint with National Cancer Institute, National Institute of Health, 1999

Specialty Certification

Licentiate of Medical Council of Canada (LMCC), 1988
Fellow, Royal College of Physicians and Surgeons of Canada (Anatomic Pathology), 1993
Diplomate of American Board of Pathology (Anatomic Pathology), 1993
Diplomate of American Board of Pathology (Hematology), 1999
Diplomate of American Board of Pathology (Molecular Genetic Pathology), 2003

Postgraduate Training

Residency in Anatomic Pathology, University of Calgary (Calgary, Alberta), 1988-1993
Chief Resident, Pathology Training Program, Foothills Hospital (Calgary, Alberta), 1991-1991
Research Fellowship, Cancer Research Group, Faculty of Medicine, University of Calgary (Calgary, Alberta), 1993-1995
Fellowship, Hematopathology, Lab of Pathology, National Cancer Institute, National Institutes of Health, (Bethesda, MD), 1995-1998
Mid-Career Women Faculty Professional Development Seminar, Association of American Medical Colleges (Washington, DC), 2003-2003
Leadership Development for Physicians in Academic Health Centers, Harvard School of Public Health (Boston, MA), 2012-2012

Awards and Honors

Louise McKinney Scholarship for Outstanding Academic Achievement, University of Calgary, 1982
Faculty of Science Dean’s List, University of Calgary, 1982
Alberta Heritage Foundation for Medical Research Studentship, 1983-1985
Alberta Heritage Foundation for Medical Research Summer Studentship, 1983
Alberta Heritage Foundation for Medical Research Part-Time Studentship (while in MD program), 1985-1987
Nominated by Medical Research Council of Canada for the Royal Society of Canada’s Women in Scholarship Alice Wilson Award, 1993
Fee Scholarship Award, Faculty of Graduate Studies, University of Calgary, 1994-1997
National Institutes of Health Fogarty Visiting Fellowship, 1996-1998
Junior Scientist Award, Canadian Association of Pathology, 2000
Young Investigator Award, Children’s Oncology Group, 2002
Translational Research Award, Children’s Oncology Group, 2004
Best Doctors of America, 2005-2014
Pluto Society, 2015
Abstract Achievement Award, American Society of Hematology, 2019-2019

Memberships and Professional Organizations

Canadian Medical Association, 1985 - 1993
Canadian Association of Pathologists, 1988 - 2017
Canadian Medical Protective Association, 1993 - 2000
Royal College of Physicians and Surgeons of Canada, 1993 - 2017
American Association for Cancer Research, 1994 - Present
Society for Hematopathology/European Association for Haemotopathology, 1995 - Present
American Society of Hematology, 1995 - Present
United States and Canadian Academy of Pathology, 1996 - Present
American Association for the Advancement of Science, 1997 - 1999
College of Physicians and Surgeons of Ontario, 1998 - 2003
European Society of Hematopathology, 1998 - 2016
Association for Molecular Pathology, 1998 - 2013
Canadian Hematology Society, 1999 - 2001
American Society of Investigative Pathology, 2002 - Present
Children’s Oncology Group, 2002 - Present
American Biologic Resources and Facilities, 2005 - 2007
American Society of Mass Spectrometry, 2006 - 2006
A. J. French Society, 2007 - 2015
Michigan Society of Pathologists, 2007 - 2015
College of American Pathologists, 2008 - Present
American Society of Clinical Pathology, 2008 - Present
American Society for Clinical Pathology, 2008 - 2012
United States Cutaneous Lymphoma Consortium, 2014 - 2014
American Association of University Pathologists - Pluto Society (elected member), 2015 - Present
University of Michigan, 2016 - 2016
Department of Defense Congressionally Directed Medical Research Programs (CDMRP) Peer Review Cancer Research Program (PRCRP) - Lymphoma (LYM), 2016 - 2019
National Science Center, Poland, 2017 - 2017
Ontario Genomics; Grant Review - Genome Canada, Large-Scale Applied Research Project on Genomics in Precision Health., 2017 - 2017
National Institutes of Health, Lymphoma and Leukemia Molecular Profiling Project Grant, 2019 - 2024
Medical Research Council of United Kingdom, 2020 - 2020

Web Links


Selected Publications

Insufficient evidence exists to use histopathologic subtype to guide treatment of idiopathic multicentric Castleman disease.

Fajgenbaum DC, Wu D, Goodman A, Wong R, Chadburn A, Nasta S, Srkalovic G, Mukherjee S, Leitch H, Jayanthan R, Ferrero S, Sato Y, Schey S, Dispenzieri A, Oksenhendler E, Zinzani PL, Lechowicz MJ, Hoffman C, Pemmaraju N, Bagg A, Fossa A, Lim MS, van Rhee F., Am J Hematol, 2020, PMID:32894785

Read article

Successful Disease Control Without Cranial Radiation in Newly Diagnosed T Lymphoblastic Lymphoma (T-LL): Results from Children’s Oncology Group AALL0434

Hayashi RJ, Winter SS, Dunsmore KP, Devidas M, Chen Z, Wood BL, Hermiston M, Teachey DT, Perkins SL, Miles RR, Raetz EA, Loh ML, Winick NJ, Carroll WL, Hunger SP, Lim MS, Gross TG, Bollard CM, J Clin Oncol, 2020, PMID:32552472

Read article

Discovery of novel recurrent mutations and clinically meaningful subgroups in nodal marginal zone lymphoma.

Koh J, Jang I, Choi S, Kim S, Jang I, Ahn HK, Lee C, PaiK JH, Kim CW, Lim MS, Kim K*, Jeon YK*, Cancers 12(6): 1669, 2020, PMID:32585984

Read article

Brentuximab Vedotin with R-CHP chemotherapy as frontline treatment for patients with CD30+ PMBCL, DLBCL, and GZL.

Svoboda J, Landsburg DJ, Dwivedy Nasta S, Blair SM, Nagle SJ, Barta SK, Khan N, Filicko-O’Hare J, Gaballa S, Strelec L, Chong E, Mitnick S, Waite TS, King C, Ballard H, Youndman M, Gerson J, Plastaras JP, Maity A, Bogusz AM, Hung SS, Nakamura H, Nejati R, Steidl C, Lim MS, Ruella M, Schuster SJ, Haematologica, 2020, PMID:32414850

Read article

Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma, Version 4.2020, NCCN Clinical Practice Guidelines in Oncology.

Wierda WG, Byrd JC, Abramson JS, Bilgrami SF, Bociek G, Brander D, Brown J, Chanan-Khan AA, Chavez JC, Coutre SE, Davis RS, Fletcher CD, Hill B, Kahl BS, Kamdar M, Kaplan LD, Khan N, Kipps TJ, Lim MS, Ma S, Malek S, Mato A, Mosse C, Shadman M, Siddiqi T, Stephens D, Sundaram S, Wagner N, Dwyer M, Sundar H., J Natl Compr Canc Netw 18(2): 185-217, 2020, PMID:32023533

Read article

Pathology and genetics of anaplastic large cell lymphoma

Levantaki V, Bhattacharyya S, Lim MS., Semin in Diag Pathol 37(): 57-71, 2020, PMID:31882178

Read article

The mechanism of cancer drug addiction in ALK-Positive T-cell lymphoma.

Rajan SS, Amin AD, Li L, Rolland DCM, Li H, Kwon D, Kweh MF, Arumoy A, Yan A, Basrur V, Elenitoba-Johnson KSJ, Chen X, Puvvada SD, Lussier YA, Bilbao D, Lim MS, Schatz JH, Oncogene, 2019, PMID:31804622

Read article

Colony-stimulating Factor 1 Receptor (CSF1R) Activates AKT/mTOR Signaling and Promotes T-cell Lymphoma Viability.

Murga-Zamalloa C, Rolland DSC, Polk A, Wolfe A, Dewar H, Chowdury P, Önder Ö, Dewar R, Brown N, Bailey N, Inamdar K, Lim MS, Elenitoba-Johnson KSJ, and Ryan Wilcox, Clinical Cancer Research, 2019, PMID:31636099

Read article

Immunophenotypic, cytotoxic, proteomic and genomic, characterization of human cord blood vs. peripheral blood CD56Dlm NK cells.

Shereck E. Day NS, Awasthi A, Ayello J, Chu Y, McGuinn C, van de Ven C, Lim MS, Cairo MS., Innate Immun., 2019, PMID:31068047

Read article